Agency:
Dr. Kaye receives research support from the NIH (U2C AG054397, P30 AG008017, R01 AG024059, P30 AG024978, P01 AG043362, U01 AG010483) and Merck; directs a center that receives research support from the NIH, CDC, Alzheimer’s Association, AbbVie, Kyowa, Glov